The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex multi-step organic process. Preliminary routes focused on protein portion coupling, utilizing solid-phase https://philippjkg577537.get-blogging.com/41139417/synthesis-and-study-implementations-of-retatrutide